Key result
ICM is linked to lower observed freedom from AF recurrence at ~51% versus conventional monitoring.
Why the study?
Monitoring of patients after catheter AF ablation varied widely, and the comparative effectiveness of different ECG monitoring strategies for detecting arrhythmia recurrences was unclear.
Does an implanted cardiac monitoring system detect more atrial fibrillation recurrences compared to TTMON, ECG, or Holter ECG in patients after catheter AF ablation?
Cohort (n=2,658)
Yes
Does an implanted cardiac monitoring system detect more atrial fibrillation recurrences compared to TTMON, ECG, or Holter ECG in patients after catheter AF ablation?
Implanted cardiac monitors detect significantly more post-ablation atrial fibrillation recurrences than intermittent monitoring strategies like ECG, Holter, or trans-telephonic monitoring.
Answers are grounded in this paper and cite their sources.
ICM was associated with higher post-ablation AF detection than intermittent monitoring; leaves open whether this alters management or outcomes.
AIMS: Monitoring of patients after ablation had wide variations in the ESC-EHRA atrial fibrillation ablation long-term (AFA-LT) registry. We aimed to compare four different monitoring strategies after catheter AF ablation. METHODS AND RESULTS: The ESC-EHRA AFA-LT registry included 3593 patients who underwent ablation. Arrhythmia monitoring during follow-up was performed by 12-lead electrocardiogram (ECG), Holter ECG, trans-telephonic ECG monitoring (TTMON), or an implanted cardiac monitoring (ICM) system. Patients were selected to a given monitoring group according to the most extensive ECG tool used in each of them. Comparison of the probability of freedom from recurrences was performed by censored log-rank test and presented by Kaplan-Meier curves. The rhythm monitoring methods were used among 2658 patients: ECG (N = 578), Holter ECG (N = 1874), TTMON (N = 101), and ICM (N = 105). A total of 767 of 2658 patients (28.9%) had AF recurrences during follow-up. Censored log-rank test discovered a lower probability of freedom from relapses, which was detected with ICM compared to TTMON, ECG, and Holter ECG (P < 0.001). The rate of freedom from AF recurrences was 50.5% among patients using the ICM while it was 65.4%, 70.6%, and 72.8% using the TTMON, ECG, and Holter ECG, respectively. CONCLUSION: Comparing all main electrocardiographic monitoring methods in a large patient sample, our results suggest that post-ablation recurrences of AF are significantly underreported by TTMON, ECG, and Holter ECG. The ICM estimates AF ablation recurrences most reliably and should be a preferred mode of monitoring for trials evaluating novel AF ablation techniques.
No takes yet. Share an insight, caveat, or question.
Balabanski et al. (2019) conducted a cohort in Atrial fibrillation (n=2,658). Implanted cardiac monitoring (ICM) vs. Trans-telephonic ECG, 12-lead ECG, and Holter ECG was evaluated on Freedom from AF recurrences (p=<0.001). Implanted cardiac monitoring detected a lower rate of freedom from atrial fibrillation recurrences compared to TTMON, ECG, and Holter ECG.
Synapse has enriched 10 related papers. Consider them for comparative context: